East Bay biotech raised about $800M in 4 years. Now it’s cutting at least 10% of jobs

The company grew quickly with the promise of using Nobel Prize-winning technology to get a real-time look at proteins, and it inked a big lease to become the anchor tenant of a Peninsula biotech campus.